178 related articles for article (PubMed ID: 6577782)
1. Influence of gemfibrozil on high-density lipoproteins.
Glueck C
Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
[TBL] [Abstract][Full Text] [Related]
2. Clinical results with gemfibrozil.
Pickering JE
Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579
[No Abstract] [Full Text] [Related]
3. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipoproteinemia, atherosclerosis and gemfibrozil.
Nash DT
Angiology; 1982 Sep; 33(9):594-602. PubMed ID: 6957155
[TBL] [Abstract][Full Text] [Related]
5. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
[TBL] [Abstract][Full Text] [Related]
6. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
Krause BR; Newton RS
J Lipid Res; 1985 Aug; 26(8):940-9. PubMed ID: 3862732
[TBL] [Abstract][Full Text] [Related]
8. Effect of gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects.
Gnasso A; Lehner B; Haberbosch W; Leiss O; von Bergmann K; Augustin J
Metabolism; 1986 May; 35(5):387-93. PubMed ID: 3458020
[TBL] [Abstract][Full Text] [Related]
9. Change in composition of high density lipoprotein during gemfibrozil therapy.
Sorisky A; Ooi TC; Simo IE; Meuffels M; Hindmarsh JT; Nair R
Atherosclerosis; 1987 Oct; 67(2-3):181-9. PubMed ID: 3118893
[TBL] [Abstract][Full Text] [Related]
10. Nutritional & pharmacologic management of hyperlipoproteinemia.
Pickering JE
Angiology; 1982 Sep; 33(9):577-80. PubMed ID: 6957154
[TBL] [Abstract][Full Text] [Related]
11. Phenylenebis(oxy)bis[2,2-dimethylpentanoic acid]s: agents that elevate high-density lipoproteins.
Sircar I; Hoefle M; Maxwell RE
J Med Chem; 1983 Jul; 26(7):1020-7. PubMed ID: 6864730
[TBL] [Abstract][Full Text] [Related]
12. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
13. Effect of gemfibrozil on serum lipids in man.
Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
Lewis JE
Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
[TBL] [Abstract][Full Text] [Related]
15. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
Manninen V
Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578
[No Abstract] [Full Text] [Related]
16. A pilot study of the effect of Gemfibrozil on some haematological parameters.
O'Brien JR; Etherington MD; Shuttleworth RD; Adams CM; Middleton JE; Goodland FC
Thromb Res; 1982 May; 26(4):275-9. PubMed ID: 6955993
[TBL] [Abstract][Full Text] [Related]
17. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
18. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
[TBL] [Abstract][Full Text] [Related]
19. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
Manninen V; Mälkönen M; Eisalo A; Virtamo J; Tuomilehto J; Kuusisto P
Acta Med Scand Suppl; 1982; 668():82-7. PubMed ID: 6762809
[No Abstract] [Full Text] [Related]
20. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]